Therapeutic manipulation of globin gene expression in the hemoglobinopathies.
作者信息
Johnson C S
出版信息
J Natl Med Assoc. 1986 Jul;78(7):599-600.
Abstract
摘要
相似文献
1
Therapeutic manipulation of globin gene expression in the hemoglobinopathies.血红蛋白病中珠蛋白基因表达的治疗性调控。
J Natl Med Assoc. 1986 Jul;78(7):599-600.
2
Stem cell gene therapy for the beta-chain hemoglobinopathies. Problems and progress.用于β链血红蛋白病的干细胞基因治疗。问题与进展。
Ann N Y Acad Sci. 1999 Apr 30;872:94-107; discussion 107-8. doi: 10.1111/j.1749-6632.1999.tb08456.x.
3
Lenti in red: progress in gene therapy for human hemoglobinopathies.红色慢病毒：人类血红蛋白病基因治疗的进展
J Clin Invest. 2004 Oct;114(7):889-91. doi: 10.1172/JCI23132.
4
Impact of epigenetic mechanisms on therapeutic approaches of hemoglobinopathies.表观遗传机制对血红蛋白病治疗方法的影响。
Blood Cells Mol Dis. 2015 Aug;55(2):95-100. doi: 10.1016/j.bcmd.2015.05.004. Epub 2015 May 12.
5
Globin gene structure in disorders of hemoglobin.血红蛋白疾病中的珠蛋白基因结构
Prog Hematol. 1981;12:25-42.
6
The impact of molecular biology on the diagnosis and treatment of hemoglobin disorders.分子生物学对血红蛋白疾病诊断和治疗的影响。
Mol Genet Med. 1992;2:1-38. doi: 10.1016/b978-0-12-462002-5.50006-6.
7
The 11th conference on hemoglobin switching. Orcas Island, Washington, USA. October 2-6, 1998. Abstracts.第十一届血红蛋白转换会议。美国华盛顿州奥卡斯岛。1998年10月2日至6日。摘要
Blood Cells Mol Dis. 1998 Dec;24(4):462-521.
8
Beta-globin gene disorders in Italy and the Mediterranean area.意大利及地中海地区的β-珠蛋白基因疾病
Horiz Biochem Biophys. 1986;8:257-98.
9
Beta-globin-gene haplotypes, mitochondrial DNA, the Y-chromosome: their impact on the genetic epidemiology of the major structural hemoglobinopathies.β-珠蛋白基因单倍型、线粒体DNA、Y染色体：它们对主要结构性血红蛋白病遗传流行病学的影响。
Cell Mol Biol (Noisy-le-grand). 2004 Feb;50(1):5-21.
10
Gene therapy for hemoglobinopathies: are we there yet?血红蛋白病的基因治疗：我们成功了吗？
Curr Hematol Rep. 2004 Jul;3(4):298-305.
本文引用的文献
1
The irreversibly sickled cell.不可逆性镰状细胞。
Am J Pediatr Hematol Oncol. 1982 Fall;4(3):307-15.
2
Mechanical properties of oxygenated red blood cells in sickle cell (HbSS) disease.镰状细胞（HbSS）病中氧合红细胞的力学特性。
Blood. 1984 Jan;63(1):73-82.
3
Bone-marrow transplantation in a patient with sickle-cell anemia.镰状细胞贫血患者的骨髓移植
N Engl J Med. 1984 Sep 20;311(12):780-3. doi: 10.1056/NEJM198409203111207.
4
DNA methylation and gene function.DNA甲基化与基因功能。
Science. 1980 Nov 7;210(4470):604-10. doi: 10.1126/science.6254144.
5
Augmentation of fetal-hemoglobin production in anemic monkeys by hydroxyurea.羟基脲增加贫血猴子胎儿血红蛋白的生成
N Engl J Med. 1984 Apr 5;310(14):869-73. doi: 10.1056/NEJM198404053101401.
6
7
Treatment of sickle cell anemia with 5-azacytidine results in increased fetal hemoglobin production and is associated with nonrandom hypomethylation of DNA around the gamma-delta-beta-globin gene complex.用5-氮杂胞苷治疗镰状细胞贫血会导致胎儿血红蛋白生成增加，并与γ-δ-β-珠蛋白基因复合体周围DNA的非随机低甲基化有关。
Proc Natl Acad Sci U S A. 1983 Aug;80(15):4842-6. doi: 10.1073/pnas.80.15.4842.
8
9
5-azacytidine selectively increases gamma-globin synthesis in a patient with beta+ thalassemia.5-氮杂胞苷可选择性增加一名β+地中海贫血患者的γ珠蛋白合成。
N Engl J Med. 1982 Dec 9;307(24):1469-75. doi: 10.1056/NEJM198212093072401.
10
Hb F synthesis in sickle cell anaemia: a comparison of Saudi Arab cases with those of African origin.镰状细胞贫血中胎儿血红蛋白（Hb F）的合成：沙特阿拉伯病例与非洲裔病例的比较。
Br J Haematol. 1980 Jul;45(3):431-45. doi: 10.1111/j.1365-2141.1980.tb07163.x.
Zotero 插件